TRIFERIC
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 01 Jun 2021)
What this means for you
Registered since 20 Oct 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86036014
- Registration number
- 4837260
- Mark type
- Stylized text
- Filed
- 13 Aug 2013
- Published for opposition
- 07 Jan 2014
- Registered
- 20 Oct 2015
- Attorney of record
- Matthew J. Gipson
Goods and services
- Class 005 — Pharmaceuticals: preparations for use in clinical and medical dialysis procedures; pharmaceutical solutions used in dialysis and hemodialysis; pharmaceutical preparations, namely, preparations for treating iron deficiency, anemia, kidney disease and renal disease; pharmaceutical preparations for injection, namely, preparations for treating iron deficiency, anemia, kidney disease and renal disease; iron delivery therapy, namely, commercial iron nutritional supplements, intravenous fluids used for the delivery of iron and soluble ferric pyrophosphate
Owner
- ROCKWELL MEDICAL, INC., WIXOM, MI, US
- ROCKWELL MEDICAL, INC., Wixom, MI, US
- ROCKWELL MEDICAL, INC., Wixom, MI, US
- ROCKWELL MEDICAL, INC., Wixom, MI, US
Prosecution history
- 20 Oct 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 01 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 01 Jun 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Jun 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Jan 2021 — TEAS SECTION 8 & 15 RECEIVED
- 20 Jan 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 20 Oct 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Oct 2015 — REGISTERED-PRINCIPAL REGISTER
- 16 Sept 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Sept 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Sept 2015 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Sept 2015 — USE AMENDMENT FILED
- 03 Sept 2015 — TEAS STATEMENT OF USE RECEIVED
- 10 Mar 2015 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Mar 2015 — SOU EXTENSION 2 GRANTED